Drug-Resistant Fungus Candida Auris Spreads to 26 States
A drug-resistant fungus, Candida auris (C. auris), has spread to 26 states in the U.S., with over 3,000 reported cases this year. The CDC reports that C. auris can cause serious or life-threatening illnesses, particularly in healthcare settings, and is…
Greenville Spartanburg Asheville Anderson, SC, August 6, 2026 —
The drug-resistant fungus known as Candida auris (C. auris) has now been reported in 26 states across the United States, with more than 3,000 cases documented this year alone. The Centers for Disease Control and Prevention (CDC) has issued warnings regarding the serious or potentially life-threatening nature of illnesses caused by C. auris, particularly within healthcare environments.
According to the CDC, C. auris exhibits resistance to common antifungal medications, posing a significant challenge for treatment. While the fungus does not typically pose a high risk to individuals with robust immune systems, vulnerable populations, including those with severe underlying medical conditions or who rely on invasive medical devices, are more susceptible to infection.
The spread of C. auris is facilitated through direct contact with infected individuals and via contaminated surfaces and medical equipment. Public health officials note a substantial increase in the prevalence of this fungus over the last ten years, highlighting the growing concern among healthcare providers and infectious disease experts.
The CDC continues to monitor the situation closely, providing guidance to healthcare facilities on infection prevention and control measures to mitigate the spread of C. auris. The agency emphasizes the importance of early detection and appropriate treatment strategies to manage infections effectively.
Story summarized from the original created by Dorothy Sedovic on www.foxcarolina.com, see more information here.
Media gallery
